Abstract
The University of Central Florida invention is an implantable medical device for targeted pain suppression. Implanted onto the dorsal root ganglia (DRG), the UCF micro liquid thermal regulator (MLTR) uses closed-loop cooling and micro-channel technology. The MLTR can reduce the temperature to as low as 10 degrees Celsius, effectively modulating internal molecular channel activity and reducing pain perception. The innovation offers a non-opioid alternative for pain management, providing precise and localized cooling to the source of pain transmission. By offering a promising solution to chronic pain, the MLTR holds the potential to enhance patient outcomes and improve quality of life.
Partnering Opportunity: The research team is seeking partners for licensing, research collaboration, or both.
Stage of Development: Prototype available.
Benefit
Enables efficient fabrication and easy customization for a versatile, adaptable deviceMLTR operates independently, needing only power for functionality, thus enhancing its potential for portabilityDoes not rely on natural cold gases or liquids, therefore eliminating the need for regular refillingMarket Application
Medical device manufacturers
Brochure
